Outsourcing as a business model within the Life Science-industry is growing year by year. Choosing the right contract development and manufacturing organization (CDMO) has become an important factor for the success of drug product development. …
The article discusses the challenges small and mid-sized companies are facing when taking AAV vector-based innovations from the laboratory bench to the clinic. While in-house manufacturing may be an option for some companies, partnering with a …
The therapeutic possibilities of cell and gene therapy are very appealing. The possibility to use a Viral Vector to carry the therapeutic gene into the target cells or to initiate cell transduction holds the potential …
Biovian’s One-Stop-Shop service concept is presented in Biopharma Dealmakers’ July edition: “Biovian: a true One-Stop-Shop CDMO with gene therapy capacity and Nordic ethos” The article describes how the Nordic Biovian delivers a comprehensive and reliable …
Biovian, a Nordic Bio-CDMO is presented in the Biopharma Dealmakers’ June edition that focuses on next-generation therapeutics. The article describes Biovian’s concept of a true One-Stop-Shop that covers both the supply chain and the value chain.
